US20090117256A1 - Method for decreasing bitterness and improving taste of protein-free and hydrolyzed infant formulas - Google Patents

Method for decreasing bitterness and improving taste of protein-free and hydrolyzed infant formulas Download PDF

Info

Publication number
US20090117256A1
US20090117256A1 US12/254,033 US25403308A US2009117256A1 US 20090117256 A1 US20090117256 A1 US 20090117256A1 US 25403308 A US25403308 A US 25403308A US 2009117256 A1 US2009117256 A1 US 2009117256A1
Authority
US
United States
Prior art keywords
protein
infant formula
produce
formula
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/254,033
Other languages
English (en)
Inventor
Khaled A. Khatib
Win-Chin Chiang
Jane Ehninger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mead Johnson Nutrition Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40403996&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20090117256(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Priority to US12/254,033 priority Critical patent/US20090117256A1/en
Assigned to BRISTOL-MYERS SQUIBB COMPANY reassignment BRISTOL-MYERS SQUIBB COMPANY ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: EHNINGER, JANE, CHIANG, WIN-CHIN, KHATIB, KHALED A.
Assigned to MJN RESTRUCTURING HOLDCO, INC. reassignment MJN RESTRUCTURING HOLDCO, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BRISTOL-MYERS SQUIBB COMPANY
Assigned to MEAD JOHNSON NUTRITION COMPANY reassignment MEAD JOHNSON NUTRITION COMPANY MERGER (SEE DOCUMENT FOR DETAILS). Assignors: MJN RESTRUCTURING HOLDCO, INC.
Publication of US20090117256A1 publication Critical patent/US20090117256A1/en
Priority to US14/844,143 priority patent/US11412768B2/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
    • A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
    • A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
    • A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
    • A23J3/343—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/86—Addition of bitterness inhibitors
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Definitions

  • the present invention relates generally to methods for decreasing bitterness and improving the taste of protein-free and hydrolyzed infant formulas.
  • Cow's milk allergy is a common food protein allergy in young children
  • the allergy occurs in about 2% to 3% of all infants.
  • One proposed explanation for the prevalence of cow's milk allergy among infants is that intact cow's milk protein, which is found in most conventional infant formulas, is the earliest and most common food allergen to which infants are exposed. In fact, about 80% of currently available formulas are based upon cow's milk.
  • infant formulas have been designed to reduce the incidence of protein allergies.
  • One such example involves the use of hydrolyzed cow's milk.
  • the proteins in hydrolyzed formulas have been treated with enzymes to break down some or most of the proteins that cause adverse symptoms with the goal of reducing allergic reactions, intolerance, and sensitization.
  • Amino acids are the basic structural building units of protein. Breaking the proteins down to their basic chemical structure by completely pre-digesting the proteins makes amino acid-based formulas the most hypoallergenic formulas available.
  • an embodiment of the invention is directed to a novel method for decreasing the bitterness or improving the taste of a hydrolyzed infant formula.
  • the method comprises intermixing a hydrolyzed protein source, a carbohydrate source, a fat source, vitamins, and minerals in a solution and then adjusting the pH of the formula to between about 6.5 and about 7.2.
  • the invention is also directed to a novel method for decreasing the bitterness or improving the taste of a protein-free infant formula.
  • the method comprises intermixing a protein equivalent source, a carbohydrate source, a fat source, vitamins, and minerals in a solution and then adjusting the pH of the formula to between about 6.5 and about 7.2.
  • infant formula mean a composition that satisfies the nutrient requirements of an infant by being a substitute for human milk.
  • the terms “partially hydrolyzed” mean a degree of hydrolysis which is greater than 0% but less than about 50%.
  • protein-free mean containing no measurable amount of protein, as measured by standard protein detection methods such as sodium dodecyl (lauryl) sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) or size exclusion chromatography.
  • the invention is directed to a novel method for decreasing the bitterness or improving the taste of a protein-free or hydrolyzed infant formula.
  • the method comprises intermixing the ingredients of the formula and adjusting the pH of the formula to between about 6.5 and about 7.2.
  • the pH of the formula may be between about 6.8 and about 7.0.
  • the pH of the formula may be between about 6.5 and about 7.0.
  • the pH of the formula may be between about 6.8 and about 7.2.
  • Typical hydrolyzed or protein-free infant formulas have a pH range of about 4.5 to 6.0.
  • the method involves increasing the pH of the infant formula from between about 4.5 and 6.0 to between about 6.8 and 7.2. This increased pH provides the formula with a decreased bitterness, an improved taste and improved tolerability among infants, and a pH that is similar to that of breast milk.
  • the pH of the formula may be adjusted using any means known in the art.
  • citric acid, sodium hydroxide, and/or potassium hydroxide may be used to adjust the pH of the formula.
  • the infant formula of the invention can be a term infant formula or a preterm infant formula.
  • the nutritional formulation of the invention can be a liquid (ready-to-use or concentrated) or powder.
  • the nutritional formulation for use in the present invention is nutritionally complete and contains suitable types and amounts of protein, free amino acids, lipids, carbohydrates, vitamins and/or minerals.
  • the protein source is hydrolyzed.
  • the protein source may comprise, but is not limited to, nonfat milk, soy protein, whey protein, casein protein, milk protein, or egg protein.
  • the protein source can be partially hydrolyzed or extensively hydrolyzed.
  • the amount of protein typically may vary from about 1 to about 5 g/100 kcal.
  • the infant formula is protein-free and contains free amino acids as a protein equivalent source.
  • the amino acids may comprise, but are not limited to, histidine, isoleucine, leucine, lysine, methionine, cysteine, phenylalanine, tyrosine, threonine, tryptophan, valine, alanine, arginine, asparagine, aspartic acid, glutamic acid, glutamine, glycine, proline, serine, carnitine, taurine and mixtures thereof.
  • the amino acids may be branched chain amino acids.
  • small amino acid peptides may be included as the protein of the present invention.
  • Such small amino acid peptides may be naturally occurring or synthesized.
  • the amount of free amino acids in the nutritional formulation may vary from about 1 to about 5 g/100 kcal. In an embodiment, 100% of the free amino acids have a molecular weight of less than 500 Daltons. In this embodiment, the nutritional formulation may be hypoallergenic.
  • lipid source Another component of the infant formula of the invention is a lipid source.
  • the amount of lipid can typically vary from about 3 to about 7 g/100 kcal.
  • Lipid sources can be any known or used in the art, including but not limited to, vegetable oils such as palm oil, canola oil, corn oil, soybean oil, palmolein, coconut oil, medium chain triglyceride oil, high oleic sunflower oil, high oleic safflower oil, and the like.
  • carbohydrate source typically can vary from about 8 to about 12 g/100 kcal.
  • Carbohydrate sources can be any known or used in the art, including but not limited to, lactose, glucose, corn syrup solids, maltodextrins, sucrose, rice syrup solids, and the like.
  • the infant formula may contain additional components, such as long chain polyunsaturated fatty acids (LCPUFAs).
  • LCPUFAs long chain polyunsaturated fatty acids
  • the infant formula may contain docosahexaenoic acid (DHA) and/or arachidonic acid (ARA).
  • DHA docosahexaenoic acid
  • ARA arachidonic acid
  • the weight ratio of ARA:DHA may be from about 1:3 to about 9:1. In one embodiment of the present invention, this ratio is from about 1:2 to about 4:1. In yet another embodiment, the ratio is from about 2:3 to about 2:1. In one particular embodiment the ratio is about 2:1. In another particular embodiment of the invention, the ratio is about 1:1.5. In other embodiments, the ratio is about 1:1.3. In still other embodiments, the ratio is about 1:1.9. In a particular embodiment, the ratio is about 1.5:1. In a further embodiment, the ratio is about 1.47:1.
  • the level of DHA may be between about 0.0% and 1.00% of fatty acids, by weight. In other embodiments, the level of DHA may be about 0.32% by weight. In some embodiments, the level of DHA may be about 0.33% by weight. In another embodiment, the level of DHA may be about 0.64% by weight. In another embodiment, the level of DHA may be about 0.67% by weight. In yet another embodiment, the level of DHA may be about 0.96% by weight. In a further embodiment, the level of DHA may be about 1.00% by weight.
  • the amount of DHA may be from about 2 mg/100 kilocalories (kcal) to about 100 mg/100 kcal. In another embodiment, the amount of DHA may be from about 5 mg/100 kcal to about 75 mg/100 kcal. In yet another embodiment, the amount of DHA may be from about 15 mg/100 kcal to about 60 mg/100 kcal.
  • the effective amount of DHA may be from about 3 mg per kg of body weight per day to about 150 mg per kg of body weight per day. In one embodiment of the invention, the amount is from about 6 mg per kg of body weight per day to about 100 mg per kg of body weight per day. In another embodiment the amount is from about 15 mg per kg of body weight per day to about 60 mg per kg of body weight per day.
  • the level of ARA may be between 0.0% and 0.67% of fatty acids, by weight. In another embodiment, the level of ARA may be about 0.67% by weight. In another embodiment, the level of ARA may be about 0.5% by weight. In yet another embodiment, the level of ARA may be between about 0.47% and 0.48% by weight.
  • the amount of ARA may be from about 4 mg/100 kilocalories (kcal) to about 100 mg/100 kcal. In another embodiment, the amount of ARA may be from about 10 mg/100 kcal to about 67 mg/100 kcal. In yet another embodiment, the amount of ARA may be from about 20 mg/100 kcal to about 50 mg/100 kcal. In a particular embodiment, the amount of ARA may be from about 25 mg/100 kcal to about 40 mg/100 kcal. In one embodiment, the amount of ARA is about 30 mg/100 kcal.
  • the effective amount of ARA may be from about 5 mg per kg of body weight per day to about 150 mg per kg of body weight per day. In one embodiment of this invention, the amount varies from about 10 mg per kg of body weight per day to about 120 mg per kg of body weight per day. In another embodiment, the amount varies from about 15 mg per kg of body weight per day to about 90 mg per kg of body weight per day. In yet another embodiment, the amount varies from about 20 mg per kg of body weight per day to about 60 mg per kg of body weight per day.
  • oils containing long chain polyunsaturated fatty acids LCPUFAs
  • an equivalent amount of an oil which is normally present in a composition such as high oleic sunflower oil, may be replaced with the LCPUFAs.
  • the source of the LCPUFAs can be any source known in the art such as marine oil, fish oil, single cell oil, egg yolk lipid, brain lipid, and the like.
  • the LCPUFAs can be in natural form or refined form.
  • the nutritional supplement may contain at least one probiotic.
  • probiotic means a microorganism that exerts beneficial effects on the health of the host. Any probiotic known in the art may be used, provided it is suitable for combination with the other components of the supplement.
  • the probiotic may be chosen from the group consisting of Lactobacillus and Bifidobacterium.
  • the probiotic can be Lactobacillus rhamnosus GG (LGG).
  • the nutritional supplement may contain at least one prebiotic.
  • prebiotic means a non-digestible food ingredient that stimulates the growth and/or activity of probiotics.
  • any prebiotic known in the art may be used, provided it is suitable for combination with the other components of the supplement.
  • the prebiotic can be selected from the group consisting of fructo-oligosaccharide (FOS), gluco-oligosaccharide, galacto-oligosaccharide, inulin, isomalto-oligosaccharide, polydextrose, xylo-oligosaccharide, and combinations thereof.
  • the prebiobic is a mixture of inulin and FOS.
  • This example illustrates an embodiment of a protein-free, amino acid-based infant formula produced according to the method of the present invention.
  • Table 1 lists the ingredients in the infant formula of Example 1.
  • This example illustrates an embodiment of a method used to raise the pH of an infant formula of the present invention.
  • the powder base, corn syrup solids, essential amino acid premix, and non-essential acid premix were mixed into a solution.
  • the pH of the solution was adjusted to about 6.8 and the solution was then pasteurized and homogenized.
  • the solution was then evaporated to reduce the water content and dried to produce a base powder.
  • the base powder was then dry blended with the dry vitamin premix, the trace/ultratrace mineral premix and the iron trituration. The blended powder was then packaged.
  • This example illustrates the improved palatability of a pH adjusted amino acid-based product.
  • Nutramigen AATM Melman Johnson Nutritionals
  • the palatability of the pH-adjusted Nutramigen AATM product was compared to the Nutramigen AATM product that had not been pH-adjusted, and with EleCare® (Abbott Nutritionals) and Neocate® (Nutricia) amino acid products, via a taste comparison.
  • the Nutramigen AATM product that was not pH adjusted was more sour (acidic) and had a stronger fish taste, with more brothy and beany characteristics than the EleCare® and Neocate® products.
  • the pH-adjusted Nutramigen AATM product had less “fishy” notes, less sour notes, was less bitter, and had less beany characteristics than the non-adjusted amino acid product.
  • the pH-adjusted Nutramigen AATM product was more similar to EleCare® and Neocate® products in taste profile than the non-adjusted amino acid product.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Pediatric Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Seasonings (AREA)
  • Medicinal Preparation (AREA)
US12/254,033 2007-11-07 2008-10-20 Method for decreasing bitterness and improving taste of protein-free and hydrolyzed infant formulas Abandoned US20090117256A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US12/254,033 US20090117256A1 (en) 2007-11-07 2008-10-20 Method for decreasing bitterness and improving taste of protein-free and hydrolyzed infant formulas
US14/844,143 US11412768B2 (en) 2007-11-07 2015-09-03 Method of improving tolerance to hypoallergenic infant formulas

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98601507P 2007-11-07 2007-11-07
US12/254,033 US20090117256A1 (en) 2007-11-07 2008-10-20 Method for decreasing bitterness and improving taste of protein-free and hydrolyzed infant formulas

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US14/844,143 Continuation US11412768B2 (en) 2007-11-07 2015-09-03 Method of improving tolerance to hypoallergenic infant formulas

Publications (1)

Publication Number Publication Date
US20090117256A1 true US20090117256A1 (en) 2009-05-07

Family

ID=40403996

Family Applications (2)

Application Number Title Priority Date Filing Date
US12/254,033 Abandoned US20090117256A1 (en) 2007-11-07 2008-10-20 Method for decreasing bitterness and improving taste of protein-free and hydrolyzed infant formulas
US14/844,143 Active US11412768B2 (en) 2007-11-07 2015-09-03 Method of improving tolerance to hypoallergenic infant formulas

Family Applications After (1)

Application Number Title Priority Date Filing Date
US14/844,143 Active US11412768B2 (en) 2007-11-07 2015-09-03 Method of improving tolerance to hypoallergenic infant formulas

Country Status (17)

Country Link
US (2) US20090117256A1 (enExample)
EP (1) EP2205100B1 (enExample)
JP (1) JP5622580B2 (enExample)
KR (1) KR20100075922A (enExample)
CN (1) CN101848649B (enExample)
AU (1) AU2008325032A1 (enExample)
BR (1) BRPI0820304A2 (enExample)
CA (1) CA2705145A1 (enExample)
ES (1) ES2436145T3 (enExample)
MX (1) MX2010004575A (enExample)
MY (1) MY158225A (enExample)
NO (1) NO20100509L (enExample)
NZ (1) NZ584322A (enExample)
PL (1) PL2205100T3 (enExample)
RU (1) RU2507863C2 (enExample)
TW (1) TWI484917B (enExample)
WO (1) WO2009061603A1 (enExample)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011073187A1 (en) * 2009-12-15 2011-06-23 Givaudan Sa Aftertaste masking
US20110195153A1 (en) * 2009-12-04 2011-08-11 Mead Johnson Nutrition Company Nutritional Formulation Comprising A Cows Milk Peptide Containing Hydrolysate And Or Peptides Derived Thereof For Tolerance Induction
US20130320259A1 (en) * 2011-01-31 2013-12-05 Björn Fischer Solvent, process for providing an absorption liquid, and use of the solvent
US9161563B2 (en) 2010-11-23 2015-10-20 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
US10391141B2 (en) 2010-11-23 2019-08-27 Societe Des Produits Nestle S.A. Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases
WO2021223836A1 (en) * 2020-05-04 2021-11-11 Symrise Ag Flavour compositions for improving taste impressions
EP3873236B1 (en) 2018-11-02 2025-02-26 Société des Produits Nestlé S.A. Powders containing a buffer salt and an amino acid, reconstitution of such a powder into a nutritional product, and methods of using such a nutritional product

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG188259A1 (en) * 2010-09-13 2013-04-30 Givaudan Sa Taste enhancement
WO2016003263A1 (en) 2014-07-01 2016-01-07 N.V. Nutricia Amino acid based diet with improved taste
WO2016126215A1 (en) * 2015-02-03 2016-08-11 Jirapinyo Pipop Amino acid-based formula and production process thereof
KR101738431B1 (ko) 2015-05-26 2017-05-22 남양유업 주식회사 살균 공정 중 파울링 감소를 위한 영유아식 조성물의 제조방법
RU2593410C1 (ru) * 2015-08-31 2016-08-10 Федеральное государственное бюджетное научное учреждение "Научный центр здоровья детей" (ФГБНУ "НЦЗД") Жировая композиция для адаптированной детской молочной смеси
CN107041546A (zh) * 2016-02-05 2017-08-15 上海他普亚贸易有限公司 一种氨基酸配方粉及其制备方法

Citations (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4075195A (en) * 1976-08-31 1978-02-21 Kraft, Inc. Debittered protein product and method for manufacture
US4282265A (en) * 1980-01-14 1981-08-04 Bristol-Myers Company Fat compositions for infant formulas
US4600588A (en) * 1980-08-20 1986-07-15 Ernster John H Milk protein hydrolysate and process of preparation
US4670268A (en) * 1985-01-29 1987-06-02 Abbott Laboratories Enteral nutritional hypoallergenic formula
US5021245A (en) * 1990-05-22 1991-06-04 Abbott Laboratories Infant formula containing a soy polysaccharide fiber source
US5066500A (en) * 1987-05-29 1991-11-19 Union Industrial Y Agro-Ganadera, S. A. (Uniasa) Infant formulas and nutrition products enriched with nucleosides and/or nucleotides and processes for their preparation
US5405637A (en) * 1993-06-30 1995-04-11 Bristol-Myers Squibb Company Milk protein partial hydrolysate and infant formula containing same
US5665415A (en) * 1995-07-26 1997-09-09 Akpharma Inc. Composition and method for increasing the pH of acid foods
US5824534A (en) * 1996-03-08 1998-10-20 Ajinomoto Co., Inc. Aminopeptidase GX, and a method of hydrolyzing a protein with the same
US5837312A (en) * 1996-09-20 1998-11-17 Abbott Laboratories Debittered protein product having improved antigenicity and method for manufacture
US6365218B1 (en) * 2000-02-04 2002-04-02 Abbott Laboratories Pediatric formula and methods for providing nutrition and improving tolerance
US6455273B1 (en) * 1998-09-16 2002-09-24 Ajinomoto Co., Inc. Method for producing a protein hydrolysate with low bitterness
US20040101596A1 (en) * 2002-09-10 2004-05-27 Ndife Louis I. Infant formula
US6863918B2 (en) * 1999-12-13 2005-03-08 N.V. Nutricia Infant formula with improved protein content
US20050175759A1 (en) * 2004-02-09 2005-08-11 Atul Singhal Newborn infant formulas and feeding methods
US20060233915A1 (en) * 2005-04-15 2006-10-19 Bristol-Myers Squibb Company Liquid nutritional product to supplement human milk

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3680346D1 (de) * 1985-01-29 1991-08-29 Abbott Lab Enterales hypoallergenisches ernaehrungsrezept.
JPH05344847A (ja) * 1991-03-01 1993-12-27 Meiji Milk Prod Co Ltd 不快味のない低抗原性たん白質分解物 及びその製造方法
AU2468292A (en) * 1991-08-30 1993-04-05 Teagasc, The Agriculture And Food Development Authority Hypoallergenic whey protein hydrolysate
US5422127A (en) * 1992-12-21 1995-06-06 Bristol-Myers Squibb Company Nutritional compositions containing vitamin D esters
CN1057127C (zh) * 1993-04-23 2000-10-04 北京大学 固定化复合外肽酶蛋白质全水解及脱苦方法
JP3222638B2 (ja) * 1993-06-11 2001-10-29 明治乳業株式会社 オリゴペプチド混合物及びその製造法
US5664415A (en) 1994-06-01 1997-09-09 Lockheed Fort Worth Company After-burning turbo-fan engine with a fixed geometry exhaust nozzle having a variable flow coefficient
JP2631202B2 (ja) * 1994-10-12 1997-07-16 天野製薬株式会社 ペプチド製造法
US6099871A (en) 1995-06-01 2000-08-08 Bristol-Myers Squibb Company Anti-regurgitation infant formula
EP0923315B1 (en) 1996-08-30 2003-12-10 Societe Des Produits Nestle S.A. Nutritional formula for phenylketonuria patients
JPH10179077A (ja) * 1996-12-20 1998-07-07 Sunstar Inc 苦味マスキング剤
JP2986764B2 (ja) * 1997-07-04 1999-12-06 明治乳業株式会社 苦味の少ないアミノ酸組成が人乳に近い高フィッシャー比ペプチドの調製方法
DE69920219T2 (de) * 1998-06-17 2005-09-22 New Zealand Dairy Board Bioaktive molke-eiweisshydrolysate
JP3579617B2 (ja) * 1999-08-18 2004-10-20 森永乳業株式会社 乳化安定性の良好な栄養組成物
AU2001254730A1 (en) * 2000-03-24 2001-10-03 Societe Des Produits Nestle S.A. Nutritional composition comprising hydrolysed protein
FI119429B (fi) 2002-09-17 2008-11-14 Danisco Hiilihydraattien uusi käyttö ja koostumukset
MY140883A (en) 2002-12-17 2010-01-29 Nestec Sa Nutritional formula comprising l (+) lactic acid
JP4740866B2 (ja) 2003-10-24 2011-08-03 ナムローゼ フェンノートシャップ ニュートリシア 乳児向けシンバイオティック組成物
US20050186188A1 (en) * 2004-02-19 2005-08-25 Peilin Guo Compositions containing probiotics and polysaccharides and methods of use
US20060286208A1 (en) * 2005-06-01 2006-12-21 Nagendra Rangavajla Methods for producing protein partial hydrolysates and infant formulas containing the same
US7618669B2 (en) * 2005-06-01 2009-11-17 Mead Johnson Nutrition Company Low-lactose partially hydrolyzed infant formula
DK1973429T3 (da) * 2006-01-04 2013-10-28 Leprino Foods Co Proteinhydrolysater og fremgangsmåde til fremstilling
CA2684929C (en) * 2007-05-18 2015-05-26 Mead Johnson Nutrition Company Acidified liquid human milk supplement

Patent Citations (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4075195A (en) * 1976-08-31 1978-02-21 Kraft, Inc. Debittered protein product and method for manufacture
US4282265A (en) * 1980-01-14 1981-08-04 Bristol-Myers Company Fat compositions for infant formulas
US4600588A (en) * 1980-08-20 1986-07-15 Ernster John H Milk protein hydrolysate and process of preparation
US4670268A (en) * 1985-01-29 1987-06-02 Abbott Laboratories Enteral nutritional hypoallergenic formula
US5066500A (en) * 1987-05-29 1991-11-19 Union Industrial Y Agro-Ganadera, S. A. (Uniasa) Infant formulas and nutrition products enriched with nucleosides and/or nucleotides and processes for their preparation
US5021245A (en) * 1990-05-22 1991-06-04 Abbott Laboratories Infant formula containing a soy polysaccharide fiber source
US5405637A (en) * 1993-06-30 1995-04-11 Bristol-Myers Squibb Company Milk protein partial hydrolysate and infant formula containing same
US5589357A (en) * 1993-06-30 1996-12-31 Bristol-Myers Squibb Company Milk protein partial hydrolysate and process for preparation thereof
US5665415A (en) * 1995-07-26 1997-09-09 Akpharma Inc. Composition and method for increasing the pH of acid foods
US5824534A (en) * 1996-03-08 1998-10-20 Ajinomoto Co., Inc. Aminopeptidase GX, and a method of hydrolyzing a protein with the same
US5837312A (en) * 1996-09-20 1998-11-17 Abbott Laboratories Debittered protein product having improved antigenicity and method for manufacture
US6455273B1 (en) * 1998-09-16 2002-09-24 Ajinomoto Co., Inc. Method for producing a protein hydrolysate with low bitterness
US6863918B2 (en) * 1999-12-13 2005-03-08 N.V. Nutricia Infant formula with improved protein content
US6365218B1 (en) * 2000-02-04 2002-04-02 Abbott Laboratories Pediatric formula and methods for providing nutrition and improving tolerance
US20040101596A1 (en) * 2002-09-10 2004-05-27 Ndife Louis I. Infant formula
US7070825B2 (en) * 2002-09-10 2006-07-04 Abbott Laboratories Infant formula
US20050175759A1 (en) * 2004-02-09 2005-08-11 Atul Singhal Newborn infant formulas and feeding methods
US20060233915A1 (en) * 2005-04-15 2006-10-19 Bristol-Myers Squibb Company Liquid nutritional product to supplement human milk

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110195153A1 (en) * 2009-12-04 2011-08-11 Mead Johnson Nutrition Company Nutritional Formulation Comprising A Cows Milk Peptide Containing Hydrolysate And Or Peptides Derived Thereof For Tolerance Induction
WO2011073187A1 (en) * 2009-12-15 2011-06-23 Givaudan Sa Aftertaste masking
CN102655766A (zh) * 2009-12-15 2012-09-05 奇华顿股份有限公司 余味掩蔽
CN102655766B (zh) * 2009-12-15 2013-12-25 奇华顿股份有限公司 余味掩蔽
US9161563B2 (en) 2010-11-23 2015-10-20 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
US10391141B2 (en) 2010-11-23 2019-08-27 Societe Des Produits Nestle S.A. Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases
US20130320259A1 (en) * 2011-01-31 2013-12-05 Björn Fischer Solvent, process for providing an absorption liquid, and use of the solvent
EP3873236B1 (en) 2018-11-02 2025-02-26 Société des Produits Nestlé S.A. Powders containing a buffer salt and an amino acid, reconstitution of such a powder into a nutritional product, and methods of using such a nutritional product
WO2021223836A1 (en) * 2020-05-04 2021-11-11 Symrise Ag Flavour compositions for improving taste impressions
CN115460933A (zh) * 2020-05-04 2022-12-09 西姆莱斯有限公司 用于改善味觉印象的风味组合物

Also Published As

Publication number Publication date
RU2010122900A (ru) 2011-12-20
TW200930309A (en) 2009-07-16
HK1148646A1 (en) 2011-09-16
ES2436145T3 (es) 2013-12-27
NZ584322A (en) 2011-08-26
NO20100509L (no) 2010-06-04
JP2011502480A (ja) 2011-01-27
BRPI0820304A2 (pt) 2017-05-23
CA2705145A1 (en) 2009-05-14
JP5622580B2 (ja) 2014-11-12
AU2008325032A1 (en) 2009-05-14
KR20100075922A (ko) 2010-07-05
MY158225A (en) 2016-09-15
EP2205100A1 (en) 2010-07-14
CN101848649A (zh) 2010-09-29
RU2507863C2 (ru) 2014-02-27
MX2010004575A (es) 2010-05-24
HK1146373A1 (en) 2011-06-03
PL2205100T3 (pl) 2014-07-31
EP2205100B1 (en) 2013-10-09
WO2009061603A1 (en) 2009-05-14
CN101848649B (zh) 2014-03-26
TWI484917B (zh) 2015-05-21
US20160255869A1 (en) 2016-09-08
US11412768B2 (en) 2022-08-16

Similar Documents

Publication Publication Date Title
US11412768B2 (en) Method of improving tolerance to hypoallergenic infant formulas
AU765986B2 (en) Composition for an infant formula having a low threonine content
US7951410B2 (en) Enteral compositions containing caseinoglycomacropeptide having an enhanced concentration of sialic acid
Layman et al. Applications for α-lactalbumin in human nutrition
AU2020257046B2 (en) Nutritional compositions comprising a casein hydrolysate, as well as dietary butyrate and/or a compound for stimulating formation of endogenous butyrate
JP2011502480A5 (enExample)
US20060286208A1 (en) Methods for producing protein partial hydrolysates and infant formulas containing the same
ZA200204504B (en) Infant formula with improved protein content.
CA2610707A1 (en) Low-lactose partially hydrolyzed infant formula
HK1217415A1 (zh) 包含辛烯基琥珀酸酐-改性木薯淀粉的营养制剂
US20060246146A1 (en) Method of increasing the salivary sialic acid content in a mammal
US20170215464A1 (en) Nutritional compositions containing dietary butyrate and uses thereof
AU2011100142A4 (en) Infant Formula: Probiotic Supplementation
HK1146373B (en) Method for decreasing bitterness and improving taste of protein-free and hydrolyzed infant formulas
NL1027262C2 (nl) Toepassing van met proline verrijkte samenstellingen voor het bereiden van voedingsmiddelen en therapeutische samenstellingen.
WO2018050708A1 (en) Spoonable nutritional composition
HK1148646B (en) Method for decreasing bitterness and improving taste of protein-free and hydrolyzed infant formulas
HK1133554A (en) Nutritional formulations containing octenyl succinate anahydride-modified tapioca starch
HK1119375A (en) Methods for producing protein partial hydrolysates and infant formulas containing the same

Legal Events

Date Code Title Description
AS Assignment

Owner name: BRISTOL-MYERS SQUIBB COMPANY, INDIANA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KHATIB, KHALED A.;CHIANG, WIN-CHIN;EHNINGER, JANE;REEL/FRAME:021760/0354;SIGNING DATES FROM 20081020 TO 20081022

AS Assignment

Owner name: MJN RESTRUCTURING HOLDCO, INC., INDIANA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BRISTOL-MYERS SQUIBB COMPANY;REEL/FRAME:022248/0663

Effective date: 20090130

Owner name: MJN RESTRUCTURING HOLDCO, INC.,INDIANA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BRISTOL-MYERS SQUIBB COMPANY;REEL/FRAME:022248/0663

Effective date: 20090130

AS Assignment

Owner name: MEAD JOHNSON NUTRITION COMPANY, INDIANA

Free format text: MERGER;ASSIGNOR:MJN RESTRUCTURING HOLDCO, INC.;REEL/FRAME:022354/0768

Effective date: 20090204

Owner name: MEAD JOHNSON NUTRITION COMPANY,INDIANA

Free format text: MERGER;ASSIGNOR:MJN RESTRUCTURING HOLDCO, INC.;REEL/FRAME:022354/0768

Effective date: 20090204

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION